Envío gratis a partir de 69,99 euros.

«Comprobar estado del pedido»

Entre a formar parte de una comunidad de amantes de los libros del mundo entero y acceda a un sinfín de ventajas. Crear una cuenta gratis

Envío gratuito con Zásilkovna para compras superiores a 59.99 €

Mensajería SEUR 4.99 € Mensajería GLS 7.99 € Mensajería Correos 5.49 € Mensajería DHL 5.49 € Punto SEUR 3.99 €

Contacto

Cómo comprar

Ayuda

Mi cuenta

▸ Vacío :-(

Envío gratis a partir de 69,99 euros.

Dosage Form Formulation Technologies for Improving Bioavailability

Name: Dosage Form Formulation Technologies for Improving Bioavailability
Brand: MDPI AG
SKU: 46223127
Price: 73.59 EUR
Availability: InStock
Author: Gábor Vasvári
ISBN: 9783725815708

Gábor Vasvári

Ádám Haimhoffer

Idioma

Inglés

Libro Tapa dura

Código Libristo: 46223127

Editores MDPI AG, julio 2024

This Special Issue welcomed original research papers, but was not limited to cooperative works betwe... Descripción completa

Código Libristo: 46223127

180 b

73.59 €

Almacenamiento externo Envío en 14-21 días

Hasta 30 días para devoluciones

Clientes que también han comprado

Il fiore nell'ombra. Percorsi attraverso il tatuaggio tradizionale giapponese Costanza Brogi

Tapa blanda

37.99 €

Jahresgedicht 2014: 365 Kurzgedichte zur aktuellen Weltgeschichte Andreas Haerdter

Tapa blanda

9.79 €

Infracciones tributarias Ministerio de Justicia

Tapa blanda

5.09 €

This Special Issue welcomed original research papers, but was not limited to cooperative works between academia and pharmaceutical companies where reformulations or original dosage form designs were performed. Papers or reviews including the principles of Quality by Design to improve the bioavailability of drugs belonging to BCS Classes of II or IV were warmly encouraged for submission. We were looking for manuscripts that optimized innovative technology through the design of experiments as well. Non-pharma institutes or departments and their innovative research projects were also invited to contribute to this Special Issue if their novel and original results could be adapted to dosage form formulation or production.